Aberrations in SPTBN1, that encodes a scaffolding cellular protein involved in the formation of the cytoskeleton, is a useful prognostic biomarker in HPV-negative HNSCCs since patients with tumours expressing SPTBN1 have four times higher mortality, compared with patients not harbouring this mutation [35]. Here, SPTBN1 is linked to neoplasm.